Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension
about
Vascular Complications of Cancer ChemotherapyMedical management of brain tumors and the sequelae of treatment.Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.Sorafenib cardiotoxicity increases mortality after myocardial infarction.Management of antiangiogenic therapy-induced hypertension.Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway.Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.Cardiovascular toxicity of anti-angiogenic drugs.Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature.Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.Epidemiology, prognosis, and treatment of resistant hypertension.Arterial hypertension and cancer.Emerging paradigms in cardiomyopathies associated with cancer therapies.Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis of More Than 20 000 Patients.Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options.Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients.Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience.First annual Canadian Cardiac Oncology Network conference.Microvascular remodelling in preeclampsia: quantifying capillary rarefaction accurately and independently predicts preeclampsia.Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab.Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Lung cancer as a cardiotoxic state: a review.Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
P2860
Q26766269-87BB915C-479B-49D0-A263-5F9D2A818CF7Q26992174-7527A1AC-D582-42AB-AABB-55501961EB8EQ33623357-5E5C3864-9527-4A07-B53E-BF943C6A7EF7Q33681995-6FF3B820-3DC9-4BAC-9504-62021EE319E5Q36170252-68630EEA-58CD-428F-BF2D-C9B15776FD10Q36664510-64A87757-9B81-4C9E-BDD4-D7E12E5B238EQ36751861-4A9BC2F0-E80F-44E5-A98C-CE9ED2AEC31BQ37038711-C0503FA8-A4CD-4103-B1FA-37519ED0BCB6Q37275313-B4F0707F-65C7-4047-A8D7-B04E04D9ED97Q37960873-37322072-4AC5-4CEE-A385-E68DD3A16F7BQ38068497-331FF0F9-C7E9-4B15-B468-E8D7116B402CQ38101885-AD3BB9D3-F68C-4C08-8F1F-CD00C8114B15Q38110711-091DE7BE-6D9B-4543-A62A-6020C895A020Q38115762-77A8EB5E-E9D9-44C3-AB28-0FE221F905A7Q38132645-38ACC469-F575-4293-86A2-89782AF08EC5Q38371293-6DD6AA71-1C76-4462-A2CF-A3BD182B11D6Q38757141-9E9350DF-1A80-45A7-8E55-201070B7176FQ39038772-DFC2B399-9049-48CD-8EEF-86EFB77EC1C5Q39186183-FC5AB784-D74A-4AF8-8C86-4BC45AE194A3Q39214055-686D497C-89B2-4650-A0F0-C3D846DD9F63Q41098209-C20DA217-9533-457C-A168-EEB30037121EQ45917757-A0B2930F-ABD6-47F7-9BB4-8754951D69D0Q46319789-FCDCC1A3-E008-4001-A266-EC63E15E8E97Q49066603-99F50D2F-6F82-42B3-B3A6-277BC67571F8Q49568718-FE5352A5-C587-44EA-8280-DD2296280FCCQ49851002-2737B2B9-7EE1-4B95-91E5-A87C6DCF6587Q50133191-87CDA2D4-FA7D-40D4-B917-A24EAC1FB6E4Q51760757-6AF22CB8-2F4F-4EA7-A07B-18E4453B71D1Q53117997-1CB8BE2E-487E-4AB4-9B79-5504769AE93AQ56991273-D9AD4803-DB17-484B-A975-C69F2C02A59F
P2860
Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of novel angiogenesis ...... system: focus on hypertension
@ast
Effects of novel angiogenesis ...... system: focus on hypertension
@en
Effects of novel angiogenesis ...... system: focus on hypertension
@nl
type
label
Effects of novel angiogenesis ...... system: focus on hypertension
@ast
Effects of novel angiogenesis ...... system: focus on hypertension
@en
Effects of novel angiogenesis ...... system: focus on hypertension
@nl
prefLabel
Effects of novel angiogenesis ...... system: focus on hypertension
@ast
Effects of novel angiogenesis ...... system: focus on hypertension
@en
Effects of novel angiogenesis ...... system: focus on hypertension
@nl
P2093
P3181
P1433
P1476
Effects of novel angiogenesis ...... system: focus on hypertension
@en
P2093
B. D. Humphreys
J. Moslehi
P304
P3181
P356
10.1161/CIRCULATIONAHA.110.992230
P407
P577
2011-10-11T00:00:00Z